PAHO and Ministry of Public Health advance timely diagnosis for people with advanced HIV disease, with support from Unitaid - Pan American Health Organization (PAHO)
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
PAHO/WHO and the Ministry of Health are conducting operational research at five health facilities to evaluate the integration of rapid diagnostic tests into health services. Santo Domingo, Dominican Republic, 7 October 2026 (PAHO) – The Pan American Health Organization/World Health Organization (PAHO/WHO), in coordination with the Ministry of Health and with support from Unitaid, is conducting operational research to strengthen the timely detection of tuberculosis, cryptococcosis, and histoplasmosis among people with advanced HIV disease (AHD). The study evaluates the use of rapid point-of-care diagnostic tests to bring diagnostic services closer to people and support timely clinical decision-making. These tools are particularly important for individuals who seek care with severely weakened immune systems, a condition in which opportunistic infections can progress rapidly and increase the risk of complications and death. The study is being implemented at five health facilities: Centro Sanitario Santo Domingo, Hospital Salvador B. Gautier, Hospital Juan Pablo Pina, Hospital Regional Universitario José María Cabral y Báez, and Hospital Infantil Robert Reid Cabral.
This article is an excerpt. To read the full content, visit the original source. Pan American Health Organization (PAHO)
Related articles
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!